Al Andalous Pharmaceutical Services (APS) a privately owned Egyptian company, established in 2006 with a two-fold mission: - Partner with international innovative pharmaceutical and medical device companies to bring innovative specialty products to Egypt and ME region - Provide world-class services and consulting to pharmaceutical industry - focus on regulatory , government affairs and clinical research services APS combines local expertise and access with a multinational perspective, building on the existing leadership and strong position of sister company Al Andalous Medical Company in the Egyptian market. Key strengths include: • - Strong senior management team with diverse experience in MNCs across the Middle East region - Deep understanding of the MENA regulatory / business environment; - Strong network and access to KOL’s in key therapeutic areas / sectors; - Strong regulatory / government relations capabilities; and, - Commitment to the highest ethical standards. APS’ therapeutic categories of interest include : - Hospital/Critical care Products - Oncology and immunology products ( biopharmaceuticals ) - Dermatology and advanced wound care - Innovative medical/Infant nutrition products - Therapeutic medical devices Current Partners Established partnership with two international companies in the field of Advanced wound care management Ongoing discussion with other potential partners for hospital products Y